Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C [Presence] in Anogenital specimen by NAA with probe detection

HSV 2 glyco B 3'+TK regC Anogn Ql NAA+pr

Definition

This assay detects herpes simplex virus (HSV) 2 using two different probes, one for genome glycoprotein B 3' end region and one for thymidine kinase region C. If either of the probes produces a sufficient signal the result is considered positive. This term was created for, but is not limited in use to, the Roche cobas® HSV 1 and 2 Test, which is intended for use as an aid in diagnosis of anogenital HSV-1 and HSV-2 infections in symptomatic patients. The cobas HSV 1 and 2 Test is not FDA cleared for use with cerebrospinal fluid (CSF) and is not intended to be used for prenatal screening or for individuals under the age of 18 years.

Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C

3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxythymidine; DNA NUCLEIC ACID PROBE; DNA probe; gG; Glycoprot; Glycoproteins; GP; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV 2 glyco B 3'+TK reg C; HSV2; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TK; TMA; Transcription mediated amplification

11 further terms